2019

Abrilumab in UC

Adalimumab in chronic pouchitis

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial

Adalimumab +/- azathioprine stop CD

Meat consumption in CD

Vedolizumab in CD

AntiTNF failure in CD

Adalimumab in pediatric CD

IFX originator or CT-P13 in CD